<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Lubyayi L</submitter><funding>Medical Research Council</funding><funding>Wellcome Trust</funding><pagination>929</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7240028</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>11</volume><pubmed_abstract>&lt;b>Background:&lt;/b> BCG has low efficacy in tropical countries. We hypothesized that maternal latent &lt;i>Mycobacterium tuberculosis (M.tb)&lt;/i> infection (LTBI) results in fetal tolerance to mycobacterial antigens and impaired responses to BCG immunization. &lt;b>Methods:&lt;/b> We enrolled 132 LTBI-positive and 150 LTBI-negative mothers and their babies in Entebbe, Uganda. Infants were BCG-immunized at birth. Cord blood and samples at weeks 1, 4, 6, 10, 14, 24, and 52 were analyzed for cytokine/chemokine responses to &lt;i>M.tb&lt;/i> antigens by Luminex 17-plex assay in 6-day whole blood cultures and antibody responses by ELISA. Of the 17 Luminex analytes, seven (IL-2, IL-5, IL-10, IL-13, IL-17A, TNF, and IFN-γ) were included in the main analysis as they were considered most likely to represent T cell </pubmed_abstract><journal>Frontiers in immunology</journal><pubmed_title>Maternal Latent &lt;i>Mycobacterium tuberculosis&lt;/i> Does Not Affect the Infant Immune Response Following BCG at Birth: An Observational Longitudinal Study in Uganda.</pubmed_title><pmcid>PMC7240028</pmcid><funding_grant_id>MC_UU_00027/5</funding_grant_id><funding_grant_id>MC_PC_17221</funding_grant_id><funding_grant_id>MR/K012126/1</funding_grant_id><funding_grant_id>MC_UP_1204/15</funding_grant_id><funding_grant_id>MR/K019708/1</funding_grant_id><funding_grant_id>MR/R005990/1</funding_grant_id><funding_grant_id>107754/Z/15/Z</funding_grant_id><funding_grant_id>MR/R005990/2</funding_grant_id><pubmed_authors>Akurut H</pubmed_authors><pubmed_authors>Nabakooza G</pubmed_authors><pubmed_authors>Hasso-Agopsowicz M</pubmed_authors><pubmed_authors>Mawa PA</pubmed_authors><pubmed_authors>Kaleebu P</pubmed_authors><pubmed_authors>Levin J</pubmed_authors><pubmed_authors>Serubanja J</pubmed_authors><pubmed_authors>Tumusiime J</pubmed_authors><pubmed_authors>Dockrell HM</pubmed_authors><pubmed_authors>Webb EL</pubmed_authors><pubmed_authors>Nakibuule M</pubmed_authors><pubmed_authors>Smith S</pubmed_authors><pubmed_authors>Tushabe JV</pubmed_authors><pubmed_authors>Cose S</pubmed_authors><pubmed_authors>Elliott AM</pubmed_authors><pubmed_authors>Aibo D</pubmed_authors><pubmed_authors>Lubyayi L</pubmed_authors></additional><is_claimable>false</is_claimable><name>Maternal Latent &lt;i>Mycobacterium tuberculosis&lt;/i> Does Not Affect the Infant Immune Response Following BCG at Birth: An Observational Longitudinal Study in Uganda.</name><description>&lt;b>Background:&lt;/b> BCG has low efficacy in tropical countries. We hypothesized that maternal latent &lt;i>Mycobacterium tuberculosis (M.tb)&lt;/i> infection (LTBI) results in fetal tolerance to mycobacterial antigens and impaired responses to BCG immunization. &lt;b>Methods:&lt;/b> We enrolled 132 LTBI-positive and 150 LTBI-negative mothers and their babies in Entebbe, Uganda. Infants were BCG-immunized at birth. Cord blood and samples at weeks 1, 4, 6, 10, 14, 24, and 52 were analyzed for cytokine/chemokine responses to &lt;i>M.tb&lt;/i> antigens by Luminex 17-plex assay in 6-day whole blood cultures and antibody responses by ELISA. Of the 17 Luminex analytes, seven (IL-2, IL-5, IL-10, IL-13, IL-17A, TNF, and IFN-γ) were included in the main analysis as they were considered most likely to represent T cell </description><dates><release>2020-01-01T00:00:00Z</release><publication>2020</publication><modification>2025-04-18T13:25:35.251Z</modification><creation>2020-06-02T07:08:18Z</creation></dates><accession>S-EPMC7240028</accession><cross_references><pubmed>32477371</pubmed><doi>10.3389/fimmu.2020.00929</doi></cross_references></HashMap>